WAKMAR2

Across TCGA pan-cancer cohorts, WAKMAR2 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated WAKMAR2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher WAKMAR2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated WAKMAR2 expression acts as an unfavorable survival marker, although some lineages such as PAAD and UCS show a favorable association.

ACC, LGG, and PAAD are the cancer types where WAKMAR2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.243	0.639	<.001	93	view →
LGG	DFS	Median	All	0.628	0.846	<.001	54	view →
PAAD	OS	Median	All	0.699	0.527	.002	42	view →
UCS	DFS	Quartile	II,III,IV	0.610	0.143	.011	24	view →
ESCA	DFS	Quartile	III,IV	0.617	0.236	.005	23	view →
BLCA	DFS	Median	III,IV	0.401	0.219	.002	22	view →
KICH	OS	Tertile	III,IV	1.000	0.660	.004	21	view →
BRCA	OS	Median	III,IV	0.875	0.777	.009	16	view →
CHOL	DFS	Quartile	All	0.879	0.178	.002	15	view →
LIHC	OS	Tertile	III,IV	0.788	0.348	.002	15	view →
THYM	OS	Median	All	1.000	0.743	.001	14	view →
LUSC	DFS	Quartile	III,IV	0.286	0.993	.021	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

WAKMAR2–ACC (DFS)

Open the ACC breakdown →